Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Fenwal recalls blood component infusion set

Lake Zurich, Ill.-based blood technology company Fenwal initiated a recall of their Blood Component Infusion Set on Oct. 4, due to incorrect labeling.

FDA clears InfiMed portable DR software

InfiMed has received FDA 510(k) approval for its i5DR digital imaging software with integration to the Samsung SDX-4336CP portable flat-panel detector.

Abbott's Xience Prime nets FDA clearance

Abbott has received FDA approval for the next-generation Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease.

iCAD and Hitachi ink distribution agreement

iCAD and Hitachi Medical Systems have reached a distribution agreement covering iCad's breast MR image analysis software and Hitachi's MR systems.

JACR: Rads find little common ground on incidental findings

Radiologists are often not on the same page when it comes to the management of incidental findings on body CT scans, according to a study published in the November issue of the Journal of the American College of Radiology.

Medtronic to conduct first in-home trial of insulin system for diabetes

Medtronic has received an Investigation Device Exemption from the FDA to conduct the first in-home clinical trial of a closed-loop system for Type 1 diabetes management. 

Robert Wood Johnson opens up healthcare quality challenge

The submission period for entries for the first phase of the Robert Wood Johnson Foundations Aligning Forces for Quality (AF4Q) Challenge ends Dec. 31. AF4Q, developed by the Princeton, N.J.based public health philanthropic organization, is an effort to assist the quality of healthcare in targeted communities as well as reduce racial and ethnic disparities and provide models for national reform.

NCI grants $2.3M for preclinical PET research

ImaginAb has been awarded $2.3 million in funding from the National Cancer Institute's (NCI) Small Business Innovation Research program to help further develop diagnostic imaging agents for PET.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.